JanOne Selects CPC Clinical Research as Trial Manager for Phase 2b Study of JAN101 for Peripheral Artery Disease Patients
CPC is an ARO recognized for its expertise in comprehensive clinical trial design and management for both national and international clinical research.
- CPC is an ARO recognized for its expertise in comprehensive clinical trial design and management for both national and international clinical research.
- CPC has over 30 years of experience in managing Phase 1 to 4 clinical trials and has provided services for over 150 clinical studies.
- "CPC has an outstanding reputation for clinical trial management and we are thrilled to have their team on board for our upcoming Phase 2b trial," said Tony Isaac, President and Chief Executive Officer of JanOne.
- JAN101 demonstrated positive results in a Phase 2a clinical trial and the Company is currently in preparations for Phase2btrials.